Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?

× No keyword cloud information.

9 in total

Review 1. Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.

Authors: Kathryn A Phillips; Su-Ying Liang; Stephanie Van Bebber
Journal: Curr Opin Mol Ther Date: 2008-06

2. Genomic testing and therapies for breast cancer in clinical practice.

Authors: Jennifer S Haas; Kathryn A Phillips; Su-Ying Liang; Michael J Hassett; Carol Keohane; Elena B Elkin; Joanne Armstrong; Michele Toscano
Journal: J Oncol Pract Date: 2011-05 Impact factor: 3.840

Review 3. A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.

Authors: Ya-Chen Tina Shih; Chun-Ru Chien
Journal: Cancer Date: 2016-11-28 Impact factor: 6.860

4. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.

Authors: Sangjung Park; Hye-Young Wang; Sunghyun Kim; Sungwoo Ahn; Dongsup Lee; Yoonjung Cho; Kwang Hwa Park; Dongju Jung; Seung Il Kim; Hyeyoung Lee
Journal: Int J Clin Exp Pathol Date: 2014-09-15

5. An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.

Authors: Tomas Philipson; Michael Eber; Darius N Lakdawalla; Mitra Corral; Rena Conti; Dana P Goldman
Journal: Health Aff (Millwood) Date: 2012-04 Impact factor: 6.301

6. Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.

Authors: Ilia L Ferrusi; Deborah A Marshall; Nathalie A Kulin; Natasha B Leighl; Kathryn A Phillips
Journal: Per Med Date: 2009-03 Impact factor: 2.512

7. Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.

Authors: Ya-Chen Tina Shih; Shelley Fuld Nasso; S Yousuf Zafar
Journal: Pharmacoeconomics Date: 2018-03 Impact factor: 4.981

8. Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics.

Authors: Lori W Lee; Christopher E C Taylor; Jean-Paul Desaulniers; Manchao Zhang; Jonas W Højfeldt; Quintin Pan; Anna K Mapp
Journal: Bioorg Med Chem Lett Date: 2009-09-01 Impact factor: 2.823

9. Media influence on Herceptin subsidization in Australia: application of the rule of rescue?

Authors: Ross Mackenzie; Simon Chapman; Glenn Salkeld; Simon Holding
Journal: J R Soc Med Date: 2008-06 Impact factor: 5.344

9 in total